These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9840108)

  • 1. Sensitivity and specificity of several immunochemical tests for colorectal cancer.
    Nakama H; Kamijo N; Miyata K; Abdul Fattah AS; Zhang B; Uehara Y
    Hepatogastroenterology; 1998; 45(23):1579-82. PubMed ID: 9840108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of immunochemical fecal tests for detection of colorectal adenomatous polyps.
    Nakama H; Fattah A; Zhang B; Uehara Y; Wang C
    Hepatogastroenterology; 2000; 47(32):386-9. PubMed ID: 10791196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia.
    Nakama H; Yamamoto M; Kamijo N; Li T; Wei N; Fattah AS; Zhang B
    Hepatogastroenterology; 1999; 46(25):228-31. PubMed ID: 10228797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia.
    Yoshinaga M; Motomura S; Takeda H; Yanagisawa Z; Ikeda K
    Am J Gastroenterol; 1995 Jul; 90(7):1076-9. PubMed ID: 7611200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower specificity of occult-blood test on stool collected by digital rectal examination.
    Zhang B; Nakama H; Fattah AS; Kamijo N
    Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report.
    Young GP; St John DJ; Winawer SJ; Rozen P;
    Am J Gastroenterol; 2002 Oct; 97(10):2499-507. PubMed ID: 12385430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods.
    Yamamoto M; Nakama H
    Hepatogastroenterology; 2000; 47(32):396-9. PubMed ID: 10791199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.
    Nakama H; Zhang B; Kamijo N
    Hepatogastroenterology; 2004; 51(59):1333-6. PubMed ID: 15362746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occult fecal blood loss--comparison of immunochemical and biochemical tests].
    Dvorák M; Kocna P; Vanícková Z
    Cas Lek Cesk; 2002 Apr; 141(7):217-9. PubMed ID: 12053757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of immunochemical fecal occult blood test for small colorectal neoplasms.
    Abdul Fattah AS; Nakama H; Zhang B; Uehara Y; Kamijo N; Fujimori K
    Eur J Med Res; 1997 May; 2(5):227-30. PubMed ID: 9153349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
    Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
    Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding.
    Nakama H; Kayano T; Katsuura T; Kamigaito T; Shimada S; Nishikawa N; Yoshii S; Kamijo N
    Hepatogastroenterology; 1999; 46(27):1730-2. PubMed ID: 10430332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of immunochemical and biochemical tests for occult hemorrhage in feces].
    Benesová A; Fric P; Zavoral M; Kocna P; Matĕjovic F; Vokrácka V; Mares K
    Cas Lek Cesk; 1993 Sep; 132(17):523-5. PubMed ID: 8402821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal adenomatous polyps detected by immunochemical occult blood screening.
    Fattah AS; Nakama H; Kamijo N; Fujimori K; Zhang B
    Hepatogastroenterology; 1998; 45(21):712-6. PubMed ID: 9684121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advantage of immunochemical fecal occult blood test in screening for colorectal cancer].
    Launoy G; Berchi C
    Bull Cancer; 2005 Oct; 92(10):885-90. PubMed ID: 16266872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer risk in first-degree relatives of patients with colorectal adenomatous polyp.
    Nakama H; Fukazawa K
    Hepatogastroenterology; 2002; 49(43):157-9. PubMed ID: 11941942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.